Corticosteroid Use During Pregnancy and Risk of Orofacial Clefts

Overview

Journal CMAJ

Date 2011 Apr 13

PMID 21482652

Citations 75

Authors

Anders Hviid

Ditte Molgaard-Nielsen

Affiliations

Soon will be listed here.

Abstract

Background: The association between the risk of orofacial clefts in infants and the use of corticosteroids during pregnancy is unclear from the available evidence. We conducted a nationwide cohort study of all live births in Denmark over a 12-year period.

Methods: We collected data on all live births in Denmark from Jan. 1, 1996, to Sept. 30, 2008. We included live births for which information was available from nationwide health registries on the use of corticosteroids during pregnancy, the diagnosis of an orofacial cleft and possible confounders.

Results: There were 832,636 live births during the study period. Exposure to corticosteroids during the first trimester occurred in 51,973 of the pregnancies. A total of 1232 isolated orofacial clefts (i.e., cleft lip, cleft palate, or cleft lip and cleft palate) were diagnosed within the first year of life, including 84 instances in which the infant had been exposed to corticosteroids during the first trimester of pregnancy. We did not identify any statistically significant increased risk of orofacial clefts associated with the use of corticosteroids: cleft lip with or without cleft palate, prevalence odds ratio (OR) 1.05 (95% confidence interval [CI] 0.80-1.38]; cleft palate alone, prevalence OR 1.23 (95% CI 0.83-1.82). Odds ratios for risk of orofacial clefts by method of delivery (i.e., oral, inhalant, nasal spray, or dermatologic and other topicals) were consistent with the overall results of the study and did not display significant heterogeneity, although the OR for cleft lip with or without cleft palate associated with the use of dermatologic corticosteroids was 1.45 (95% CI 1.03-2.05).

Interpretation: Our results add to the safety information on a class of drugs commonly used during pregnancy. Our study did not show an increased risk of orofacial clefts with the use of corticosteroids during pregnancy. Indepth investigation of the pattern of association between orofacial clefts and the use of dermatologic corticosteroids during pregnancy indicated that this result did not signify a causal connection and likely arose from multiple statistical comparisons.

Citing Articles

Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review.

Sousa P, Gisbert J, Julsgaard M, Selinger C, Chaparro M J Crohns Colitis. 2024; 18(Supplement_2):ii16-ii30.

PMID: 39475080 PMC: 11523042. DOI: 10.1093/ecco-jcc/jjae048.

Increased prevalence of negative pregnancy and fetal outcomes in women with primary adrenal insufficiency. A systematic review and meta-analysis.

Ilia G, Paltoglou G, Chatzakis C, Christopoulos P, Tzitiridou-Chatzopoulou M, Mastorakos G Endocrine. 2024; 86(3):1156-1170.

PMID: 39277840 DOI: 10.1007/s12020-024-04023-8.

Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.

Imai H, Watanabe N, Hirose R, Koshibu M, Ichikawa M, Sankoda A Eur Thyroid J. 2024; 13(5).

PMID: 39213615 PMC: 11558916. DOI: 10.1530/ETJ-24-0128.

Neonatal B-Cell Levels and Infant Health in Newborns Potentially Exposed to Anti-CD20 Monoclonal Antibodies During Pregnancy or Lactation.

Schwake C, Steinle J, Thiel S, Timmesfeld N, Haben S, Ayzenberg I Neurol Neuroimmunol Neuroinflamm. 2024; 11(4):e200264.

PMID: 38870458 PMC: 11178251. DOI: 10.1212/NXI.0000000000200264.

Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review.

Rohini S, Sharma U, Vinutha M, Shreelaxmi D, Vada S, Janandri S Inflammopharmacology. 2024; 32(4):1-17.

PMID: 38691248 DOI: 10.1007/s10787-024-01482-3.

References

Metneki J, Puho E, Czeizel A . Maternal diseases and isolated orofacial clefts in Hungary. Birth Defects Res A Clin Mol Teratol. 2005; 73(9):617-23. DOI: 10.1002/bdra.20177. View

Turpeinen M, Mashkilleyson N, BJORKSTEN F, Salo O . Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dermatitis in adults. Acta Derm Venereol. 1988; 68(4):331-5. View

Leite I, Paumgartten F, Koifman S . Chemical exposure during pregnancy and oral clefts in newborns. Cad Saude Publica. 2002; 18(1):17-31. DOI: 10.1590/s0102-311x2002000100003. View

Andersen T, Madsen M, Jorgensen J, Mellemkjoer L, Olsen J . The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46(3):263-8. View

Bille C, Olsen J, Vach W, Knudsen V, Olsen S, Rasmussen K . Oral clefts and life style factors--a case-cohort study based on prospective Danish data. Eur J Epidemiol. 2007; 22(3):173-81. DOI: 10.1007/s10654-006-9099-5. View

Czeizel A, Rockenbauer M . Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1998; 56(5):335-40. DOI: 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W. View

Wyszynski D, Beaty T, Maestri N . Genetics of nonsyndromic oral clefts revisited. Cleft Palate Craniofac J. 1996; 33(5):406-17. DOI: 10.1597/1545-1569_1996_033_0406_gonocr_2.3.co_2. View

NASJLETI C, AVERY J, SPENCER H, WALDEN J . Tritiated cortisone distribution and induced cleft palate in mice. J Oral Ther Pharmacol. 1967; 4(1):71-82. View

Mossey P . Epidemiology underpinning research in the aetiology of orofacial clefts. Orthod Craniofac Res. 2007; 10(3):114-20. DOI: 10.1111/j.1601-6343.2007.00398.x. View

10.

Fraser F, Sajoo A . Teratogenic potential of corticosteroids in humans. Teratology. 1995; 51(1):45-6. DOI: 10.1002/tera.1420510107. View

11.

Saxen I . Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol. 1975; 4(1):37-44. DOI: 10.1093/ije/4.1.37. View

12.

Rodriguez-Pinilla E, Martinez-Frias M . Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998; 58(1):2-5. DOI: 10.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4. View

13.

Chi C, Lee C, Wojnarowska F, Kirtschig G . Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2009; (3):CD007346. DOI: 10.1002/14651858.CD007346.pub2. View

14.

Puho E, Szunyogh M, Metneki J, Czeizel A . Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J. 2007; 44(2):194-202. DOI: 10.1597/05-208.1. View

15.

Carmichael S, Shaw G, Ma C, Werler M, Rasmussen S, Lammer E . Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007; 197(6):585.e1-7. DOI: 10.1016/j.ajog.2007.05.046. View

16.

Edwards M, Agho K, Attia J, Diaz P, Hayes T, Illingworth A . Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A. 2003; 120A(4):459-63. DOI: 10.1002/ajmg.a.20130. View

17.

Larsen H, Nielsen G, Bendsen J, Flint C, Olsen J, Sorensen H . Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003; 31(1):12-6. DOI: 10.1080/14034940210134194. View

18.

Erickson J . Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study. Teratology. 1991; 43(1):41-51. DOI: 10.1002/tera.1420430106. View

19.

Walker B . Induction of cleft palate in rabbits by several glucocorticoids. Proc Soc Exp Biol Med. 1967; 125(4):1281-4. DOI: 10.3181/00379727-125-32335. View

20.

Shah R, Kilistoff A . Cleft palate induction in hamster fetuses by glucocorticoid hormones and their synthetic analogues. J Embryol Exp Morphol. 1976; 36(1):101-8. View